Sanofi says Zaltrap approved in Europe for colorectal cancer

PARIS Tue Feb 5, 2013 1:17am EST

PARIS Feb 5 (Reuters) - French drugmaker Sanofi said on Tuesday that its Zaltrap drug had been approved for marketing in the European Union to treat metastatic colorectal cancer.

The approval came after a recent late-stage study of the drug showed significant improvement in survival among patients with colon cancer.

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.